Results 91 to 100 of about 36,527 (232)
Molecular imprinting for neurology: Materials, applications, and limitations
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma +3 more
wiley +1 more source
SERUM AMYLOID A: A KEY MEDIATOR IN INFLAMMATION, METABOLIC DISORDERS AND CARDIOVASCULAR DISEASE [PDF]
Introduction: Serum Amyloid A (SAA) is a critical acute-phase protein involved in a range of physiological and pathological processes, including inflammation, lipid metabolism, and the regulation of the immune system.
Ademira Borisova, Armine Grigoryan
doaj +1 more source
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans. [PDF]
Amyloid β (Aβ) peptides are proteolytic products from amyloid precursor protein (APP) and are thought to play a role in Alzheimer disease (AD) pathogenesis. While much is known about molecular mechanisms underlying cerebral Aβ accumulation in familial AD,
Henrik Zetterberg +19 more
doaj +1 more source
Alzheimer's disease diagnosis relies on costly, invasive positron emission tomography (PET) imaging and cerebrospinal fluid (CSF) analysis, limiting clinical use. This review summarizes a blood‐based biochemical mass spectrometry platform for early Alzheimer's disease (AD) detection, with non‐invasiveness, high sensitivity (fg/mL level), high ...
Yujian Xie +3 more
wiley +1 more source
\u3cem\u3eDe Novo\u3c/em\u3e [PSI\u3csup\u3e+\u3c/sup\u3e] Prion Formation Involves Multiple Pathways to Form Infectious Oligomers [PDF]
Prion and other neurodegenerative diseases are associated with misfolded protein assemblies called amyloid. Research has begun to uncover common mechanisms underlying transmission of amyloids, yet how amyloids form in vivo is still unclear. Here, we take
Manogaran, Anita L. +5 more
core +1 more source
Why are Functional Amyloids Non-Toxic in Humans? [PDF]
Amyloids were first identified in association with amyloidoses, human diseases in which proteins and peptides misfold into amyloid fibrils. Subsequent studies have identified an array of functional amyloid fibrils that perform physiological roles in ...
Hewitt, EW, Jackson, MP
core +2 more sources
Graphical abstract summarizing the multifactorial pathogenesis of rheumatoid arthritis (RA) and the therapeutic potential of mesenchymal stromal cell (MSC) therapy. MSCs provide promising benefits through their immunomodulatory properties, low immunogenicity, ability to promote tissue repair, and multi‐lineage differentiation, presenting a potential ...
Yingjia Chen +6 more
wiley +1 more source
mtDNA copy number associated with age of onset in familial amyloid polyneuropathy [PDF]
background Transthyretin-related familial amyloid polyneuropathy (TTR-Fap Val30Met) shows a wide variation in age-at-onset (aO) between generations and genders, as in portuguese families, where women display a later onset and a larger anticipation (>10 ...
Alonso, I +9 more
core +1 more source
Abstract figure legend Schematic illustration of the bidirectional causative link between cerebral amyloid‐beta (Aβ) angiopathy and cardiovascular disease in Alzheimer's disease (AD). Common cardiovascular risk factors like microvascular thrombosis, diabetes, atrial fibrillation, hypertension and atherosclerosis lead to cerebral hypoperfusion and ...
Samuel Parker +2 more
wiley +1 more source
Advances in cardiac devices and bioelectronics augmented with artificial intelligence
Abstract figure legend Interfaces between the human heart, diagnostic bioelectronics, artificial intelligence, and clinical care. From left to right: Human heart and biosensor interface; representative waveforms of common diagnostic bioelectronic sensing modalities.
Charles Stark +3 more
wiley +1 more source

